Stanislaw Burzynski |
Johanna Budwig |
Evangelos Michelakis |
Three "Easy" Cancer Cures Claimed; Can It Be True?
By James Donahue
After years of watching friends, family and neighbors suffer from the agony of losing battles against cancer we suddenly have news of three different claims of newly discovered “simple” cures that have either been held back by the U.S. Food and Drug Administration (FDA) or their practitioners have been forced to work in other countries.
After the agony of watching my wife die of pancreatic cancer even as my brother was going through a long and losing battle against brain cancer this writer looks at these claims with discernment, wondering if knowing might have made a difference.
Many critics have long suspected that effective cancer cures have been held back for years because of the powerful medical industry that specializes in oncology. There is an entire industry built around the field of oncology, from the costly years of study the doctors have invested to the massive and specialized chemotherapy equipment placed in hospital cancer clinics.
Even now big pharmaceutical companies are battling over a newly developed drug called Xtandi that is said to be effective against prostate cancer. The drug, developed at UCLA, is being sold by the San Francisco biotech firm Medivation at a cost of about $129,000 a year. This is the kind of big money that is at stake if easy "home remedies" against cancer are ever discovered.
And it may just be that they have.
We recently found a story about Johanna Budwig, a German scientist who discovered a cancer cure in 1951 while researching the effect of hardening oils, or trans-fatty acids on the human body. Not only did Budwig discover that these acids are extremely harmful, but she stumbled on a cure for most types of cancer as well as other diseases like arthritis, diabetes, cardiovascular problems and liver issues.
Budwig, who holds doctorates in medicine and pharmaceutical chemistry, found herself shut out by the medical community. “I have the answer to cancer but American doctors won’t listen,” she said. “They come here and observe my methods and are impressed. Then they want to make a special deal so they can take it home and make a lot of money. I won’t do it so I am blackballed.”
Budwig said she found that cancer cells are regular cells that lack the right ingredients at the molecular level to mature properly. The human body is constantly reproducing itself so as old cells die new ones grow to take their place. But as we age, and probably because we live in a growing toxic environment, the natural development of new cells gets interrupted.
Budwig’s cure for cancer, which has reportedly shown a 90 percent success rate, involves nutrition and diet changes. The diet contains no additives and no animal products except for cottage cheese combined with flaxseed oil.
She said the combination of protein and oil provides the right nutrients on a molecular level. When this treatment is applied, cancers cells are absorbed and sloughed off and the body becomes completely healthy within three months.
Budwig has written and published books and articles about her discovery, but she has spent much time in litigation just to have her work published. To date much of her work has been restricted by the courts.
You can fine Budwig’s recipe for health by visiting this site.
A second potential cancer cure discovered by Dr. Stanislaw Burzynski of Houston, Texas has just been formally approved by the FDA for clinical testing. Burzynski, who has been using his treatment and using Texas state laws to stay one step ahead of litigators, says he has treated thousands of cancer patients and had about a 50 percent success rate at curing certain types of cancer.
Burzynski says he is using injections of antineoplastons, combined with the new gene-targeted therapy to cure inoperable pediatric brainstem tumors in children. He believes the treatment may attack other forms of cancer plus AIDS, lupus and other illnesses.
Burzynski has come under heavy attack in the 36 years that he has been applying his treatments. Various newspaper and magazine publications have accused him of fraud. A federal grand jury indicted him on felony charges in 1995. After a court ordered him to stop prescribing antineoplastons, dozens of patients went to Washington to speak on his defense. The FDA gave in to the pressure and allowed the clinic to continue operating.
Lastly a research team at the University of Alberta in Edmonton, Canada, says it has successfully treated cancers in rats with salts of dichloroacetate acid (DCA), an analogue of acetic acid. When fed with water supplemented with DCA, cancer tumors on rats shrank while healthy cells remained intact.
Dr. Evangelos Michelakis of the Alberta Department of Medicine, said the studies have shown that DCA causes regression in several cancers including lung, breast and brain tumors.
While DCA suggests a possible method of treating cancer tumors, physicians warn that the available evidence does not yet support the use of DCA as a real cancer treatment. Laura Shanner, Associate Professor of Health Ethics at Alberta warns of possible problems if people attempt to by-pass known medical treatments and attempt to cure themselves with DCA.
DCA causes some side effects in the nervous system which sometimes can have serious implications.
There reportedly were five human patients treated for cancer with DCA under controlled conditions. All five patients also received other treatments during the study. The study suggested that DCA may act against cancer cells by depolarizing and causing death of the malignant cells and “some activity against very malignant, undifferentiated cells.”
While the University of Alberta medical staff is still taking a cautious approach to the use of DCA for treating malignant tumors, the staff at Medicor Cancer Centres, a holistic medical facility in North York, Ontario, has been supervising the treatment of cancer patients with DCA therapy since 2007. In the Medicor website the Canadian workers say they have treated over 1,500 patients.
The site states: “Even though we are not conducting a clinical trial, the experience gained by treating this large number of patients is extraordinary, and helps us to use DCA safely and effectively.”
The website notes that most of the patients treated at Medicor have exhausted convention treatment options. They are treated at the facility with combination therapy of DCA and one or two other drugs. The doctors there say they find that DCA works better in combination with other agents over a prolonged period of time.
“All of our patients understand that a positive to DCA treatment is not a guarantee and just like most chemotherapies, the individual response varies,” the statement said.
A treatment success rate is not specifically reported on the Medicor, although one statistic published noted that during one treatment period, 44 percent of the patients died. The clinic noted that the deaths were in no way related to the DCA treatment, however.
In Toronto, Canada, a Medicor center operated by Drs. Humaira and Akbar Khan, a husband and wife team, say they are perhaps the first in Canada to prescribe DCA to cancer patients.
The doctors say that after learning about the University of Alberta success with DCA with rats, they began using DCA to treat cancer patients who have exhausted all other treatments.
They are doing this even though they understand that DCA can be toxic and possibly cause nerve damage.
By James Donahue
After years of watching friends, family and neighbors suffer from the agony of losing battles against cancer we suddenly have news of three different claims of newly discovered “simple” cures that have either been held back by the U.S. Food and Drug Administration (FDA) or their practitioners have been forced to work in other countries.
After the agony of watching my wife die of pancreatic cancer even as my brother was going through a long and losing battle against brain cancer this writer looks at these claims with discernment, wondering if knowing might have made a difference.
Many critics have long suspected that effective cancer cures have been held back for years because of the powerful medical industry that specializes in oncology. There is an entire industry built around the field of oncology, from the costly years of study the doctors have invested to the massive and specialized chemotherapy equipment placed in hospital cancer clinics.
Even now big pharmaceutical companies are battling over a newly developed drug called Xtandi that is said to be effective against prostate cancer. The drug, developed at UCLA, is being sold by the San Francisco biotech firm Medivation at a cost of about $129,000 a year. This is the kind of big money that is at stake if easy "home remedies" against cancer are ever discovered.
And it may just be that they have.
We recently found a story about Johanna Budwig, a German scientist who discovered a cancer cure in 1951 while researching the effect of hardening oils, or trans-fatty acids on the human body. Not only did Budwig discover that these acids are extremely harmful, but she stumbled on a cure for most types of cancer as well as other diseases like arthritis, diabetes, cardiovascular problems and liver issues.
Budwig, who holds doctorates in medicine and pharmaceutical chemistry, found herself shut out by the medical community. “I have the answer to cancer but American doctors won’t listen,” she said. “They come here and observe my methods and are impressed. Then they want to make a special deal so they can take it home and make a lot of money. I won’t do it so I am blackballed.”
Budwig said she found that cancer cells are regular cells that lack the right ingredients at the molecular level to mature properly. The human body is constantly reproducing itself so as old cells die new ones grow to take their place. But as we age, and probably because we live in a growing toxic environment, the natural development of new cells gets interrupted.
Budwig’s cure for cancer, which has reportedly shown a 90 percent success rate, involves nutrition and diet changes. The diet contains no additives and no animal products except for cottage cheese combined with flaxseed oil.
She said the combination of protein and oil provides the right nutrients on a molecular level. When this treatment is applied, cancers cells are absorbed and sloughed off and the body becomes completely healthy within three months.
Budwig has written and published books and articles about her discovery, but she has spent much time in litigation just to have her work published. To date much of her work has been restricted by the courts.
You can fine Budwig’s recipe for health by visiting this site.
A second potential cancer cure discovered by Dr. Stanislaw Burzynski of Houston, Texas has just been formally approved by the FDA for clinical testing. Burzynski, who has been using his treatment and using Texas state laws to stay one step ahead of litigators, says he has treated thousands of cancer patients and had about a 50 percent success rate at curing certain types of cancer.
Burzynski says he is using injections of antineoplastons, combined with the new gene-targeted therapy to cure inoperable pediatric brainstem tumors in children. He believes the treatment may attack other forms of cancer plus AIDS, lupus and other illnesses.
Burzynski has come under heavy attack in the 36 years that he has been applying his treatments. Various newspaper and magazine publications have accused him of fraud. A federal grand jury indicted him on felony charges in 1995. After a court ordered him to stop prescribing antineoplastons, dozens of patients went to Washington to speak on his defense. The FDA gave in to the pressure and allowed the clinic to continue operating.
Lastly a research team at the University of Alberta in Edmonton, Canada, says it has successfully treated cancers in rats with salts of dichloroacetate acid (DCA), an analogue of acetic acid. When fed with water supplemented with DCA, cancer tumors on rats shrank while healthy cells remained intact.
Dr. Evangelos Michelakis of the Alberta Department of Medicine, said the studies have shown that DCA causes regression in several cancers including lung, breast and brain tumors.
While DCA suggests a possible method of treating cancer tumors, physicians warn that the available evidence does not yet support the use of DCA as a real cancer treatment. Laura Shanner, Associate Professor of Health Ethics at Alberta warns of possible problems if people attempt to by-pass known medical treatments and attempt to cure themselves with DCA.
DCA causes some side effects in the nervous system which sometimes can have serious implications.
There reportedly were five human patients treated for cancer with DCA under controlled conditions. All five patients also received other treatments during the study. The study suggested that DCA may act against cancer cells by depolarizing and causing death of the malignant cells and “some activity against very malignant, undifferentiated cells.”
While the University of Alberta medical staff is still taking a cautious approach to the use of DCA for treating malignant tumors, the staff at Medicor Cancer Centres, a holistic medical facility in North York, Ontario, has been supervising the treatment of cancer patients with DCA therapy since 2007. In the Medicor website the Canadian workers say they have treated over 1,500 patients.
The site states: “Even though we are not conducting a clinical trial, the experience gained by treating this large number of patients is extraordinary, and helps us to use DCA safely and effectively.”
The website notes that most of the patients treated at Medicor have exhausted convention treatment options. They are treated at the facility with combination therapy of DCA and one or two other drugs. The doctors there say they find that DCA works better in combination with other agents over a prolonged period of time.
“All of our patients understand that a positive to DCA treatment is not a guarantee and just like most chemotherapies, the individual response varies,” the statement said.
A treatment success rate is not specifically reported on the Medicor, although one statistic published noted that during one treatment period, 44 percent of the patients died. The clinic noted that the deaths were in no way related to the DCA treatment, however.
In Toronto, Canada, a Medicor center operated by Drs. Humaira and Akbar Khan, a husband and wife team, say they are perhaps the first in Canada to prescribe DCA to cancer patients.
The doctors say that after learning about the University of Alberta success with DCA with rats, they began using DCA to treat cancer patients who have exhausted all other treatments.
They are doing this even though they understand that DCA can be toxic and possibly cause nerve damage.